Growth Metrics

Neogenomics (NEO) Total Non-Current Liabilities (2016 - 2025)

Neogenomics (NEO) has disclosed Total Non-Current Liabilities for 14 consecutive years, with $435.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities changed 0.12% year-over-year to $435.0 million, compared with a TTM value of $435.0 million through Dec 2025, changed 0.12%, and an annual FY2025 reading of $435.0 million, changed 0.12% over the prior year.
  • Total Non-Current Liabilities was $435.0 million for Q4 2025 at Neogenomics, down from $438.6 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $676.4 million in Q3 2021 and bottomed at $433.5 million in Q1 2025.
  • Average Total Non-Current Liabilities over 5 years is $575.0 million, with a median of $641.8 million recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities skyrocketed 265.36% in 2021, then crashed 32.47% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $674.3 million in 2021, then dropped by 3.29% to $652.1 million in 2022, then dropped by 1.33% to $643.4 million in 2023, then plummeted by 32.47% to $434.5 million in 2024, then grew by 0.12% to $435.0 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for NEO at $435.0 million in Q4 2025, $438.6 million in Q3 2025, and $439.8 million in Q2 2025.